Analyst David Adlington from JP Morgan
research considers the stock attractive and recommends it with a Buy
rating. The target price continues to be set at EUR 90.80.
https://www.marketscreener.com/FRESENIUS-MEDICAL-CARE-AG-436087/news/FMC-FRESENIUS-MEDICAL-CARE-AG-CO-KGAA-JP-Morgan-reiterates-its-Buy-rating-30453918/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.